-
ARK Genomic Revolution ETF (ARKG $25.27)
- $25.27 Fwd P/E: 20.56X Cap: $860M
- View ARKG Profile
- View Questions on ARKG
Detailed Quote
Questions on this company?
Become a Member
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
ARK Genomic Revolution ETF (ARKG $25.27)
- $25.27 Fwd P/E: 20.56X Cap: $860M
- View ARKG Profile
- View Questions on ARKG
Q: Why (ARKG) has recently experienced a notable increase in value? ThankYou
-
iShares Biotechnology ETF (IBB $131.59)
- $131.59 Fwd P/E: 40.21X Cap: $5.55B
- View IBB Profile
- View Questions on IBB
-
SPDR Biotech ETF (XBI $87.02)
- $87.02 Fwd P/E: 25.15X Cap: $5.14B
- View XBI Profile
- View Questions on XBI
-
Natera Inc. (NTRA $160.43)
- $160.43 Cap: $21.90B
- View NTRA Profile
- View Questions on NTRA
-
ARK Genomic Revolution ETF (ARKG $25.27)
- $25.27 Fwd P/E: 20.56X Cap: $860M
- View ARKG Profile
- View Questions on ARKG
-
Catalyst Pharmaceuticals Inc. (CPRX $21.81)
- $21.81 Fwd P/E: 13.92X Cap: $2.66B
- View CPRX Profile
- View Questions on CPRX
Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,
Jason
Jason
-
ARK Innovation ETF (ARKK $72.29)
- $72.29 Fwd P/E: 141.98X Cap: $5.63B
- View ARKK Profile
- View Questions on ARKK
-
Invesco WilderHill Clean Energy ETF (PBW $22.11)
- $22.11 Fwd P/E: 24.13X Cap: $303M
- View PBW Profile
- View Questions on PBW
-
ARK Genomic Revolution ETF (ARKG $25.27)
- $25.27 Fwd P/E: 20.56X Cap: $860M
- View ARKG Profile
- View Questions on ARKG
Q: Hello, I have bought these during Covid and now >70% down. They are in TFSA and RESP so I can’t claim the tax loss. I don’t need the money for next 5 years in RESP, and can hold for long time in TFSA, would you suggest holding them or take a loss and use the rest of the funds somewhere else (VRT or GOOGL)? Thank for your service.
Regards
Rahul
Regards
Rahul
Insiders
Share Information
SEC Filings
News and Media